Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 3
1949 1
1950 3
1953 11
1954 11
1955 7
1956 7
1957 1
1959 6
1960 7
1961 7
1962 5
1963 5
1964 14
1965 7
1966 8
1967 11
1968 16
1969 13
1970 33
1971 19
1972 33
1973 21
1974 13
1975 12
1976 32
1977 32
1978 62
1979 81
1980 62
1981 58
1982 62
1983 65
1984 64
1985 70
1986 70
1987 84
1988 91
1989 114
1990 99
1991 118
1992 204
1993 252
1994 324
1995 285
1996 308
1997 324
1998 427
1999 453
2000 476
2001 529
2002 585
2003 805
2004 762
2005 723
2006 678
2007 708
2008 812
2009 782
2010 830
2011 805
2012 880
2013 830
2014 877
2015 921
2016 1055
2017 1138
2018 1219
2019 1273
2020 1348
2021 1232
2022 920
2023 929
2024 1426
2025 1809
2026 1268

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27,356 results

Results by year

Filters applied: . Clear all
Page 1
Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
Grabowski H. Grabowski H. Pharmacoeconomics. 2004;22(2 Suppl 2):15-24. doi: 10.2165/00019053-200422002-00003. Pharmacoeconomics. 2004. PMID: 15660474 Review.
Pharmaceutical research and development (R&D) competition in the 1980s and 1990 s was characterised by rising R&D expenditures, favourable returns to innovators and the introduction of many new classes of drugs with high social benefits. ...These include a wave of …
Pharmaceutical research and development (R&D) competition in the 1980s and 1990 s was characterised by rising R&D expenditure …
A tele-pharmacy update.
Wertheimer A. Wertheimer A. Int J Pharm Pract. 2019 Jun;27(3):221-222. doi: 10.1111/ijpp.12523. Epub 2019 Apr 26. Int J Pharm Pract. 2019. PMID: 31025429 No abstract available.
Estrogen therapy: economic considerations.
Sarrel PM. Sarrel PM. Menopause. 2018 May;25(5):481-482. doi: 10.1097/GME.0000000000001093. Menopause. 2018. PMID: 29509597 No abstract available.
Anaesthesia pharmacoeconomics.
Bevan DR. Bevan DR. Can J Anaesth. 1993 Aug;40(8):693-5. doi: 10.1007/BF03009762. Can J Anaesth. 1993. PMID: 8403152 English, French. No abstract available.
Drug discovery.
Kennedy D. Kennedy D. Science. 2004 Mar 19;303(5665):1729. doi: 10.1126/science.303.5665.1729. Science. 2004. PMID: 15031461 No abstract available.
Pharmacoeconomic principles.
Talley CR. Talley CR. Am J Health Syst Pharm. 1995 Sep 1;52(17):1871. doi: 10.1093/ajhp/52.17.1871. Am J Health Syst Pharm. 1995. PMID: 8528847 No abstract available.
The "Pharmacoeconomics" of Delivering Babies.
Rosselli D. Rosselli D. Value Health Reg Issues. 2022 Jul;30:168-169. doi: 10.1016/j.vhri.2022.05.005. Epub 2022 Jun 11. Value Health Reg Issues. 2022. PMID: 35696900 Free article. No abstract available.
27,356 results
You have reached the last available page of results. Please see the User Guide for more information.